Trial intelligence / Profile preview

Equivalent efficacy and safety study of 5% minoxidil foam versus ROGAINE in adult men with androgenetic alopecia

CTR20244862Phase 3Completed

Sponsor
山西振东安欣生物制药有限公司
Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of minoxidil in androgenetic alopecia (AGA), sponsored by 山西振东安欣生物制药有限公司. Started Dec 2024; status: completed.

02

Drugs

minoxidil
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on CTR20244862.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20244862.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call